Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Hampshire Health Report.
Press releases published on May 21, 2025
Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline
GlobeNewswire
·
May 21, 2025
Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline Paris, May 22, 2025. Sanofi announced today that it has entered into an agreement to acquire Vigil Neuroscience, Inc. …
Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters’ Option to Purchase Additional Shares, and Closing of Private Placement
GlobeNewswire
·
May 21, 2025
Public offering results in gross proceeds of $57.5 million Private placement results in gross proceeds of approximately $20.3 million GERMANTOWN, Md., May 21, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology …
Vaxart Announces Adjournment of Annual Meeting of Stockholders
GlobeNewswire
·
May 21, 2025
Meeting adjourned to June 2, 2025 at 8:30 a.m. Pacific Time Vaxart encourages all stockholders of record on March 26, 2025 who have not yet voted to do so by 11:59 p.m. Eastern Time on June 1, 2025 SOUTH SAN FRANCISCO, Calif., May 21, 2025 (GLOBE NEWSWIRE) …
Cellectis’ Annual Shareholders General Meeting to be Held on June 26, 2025
GlobeNewswire
·
May 21, 2025
NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today …
Olema Oncology to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 21, 2025
SAN FRANCISCO, May 21, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for …
CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report
GlobeNewswire
·
May 21, 2025
Accelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to responsible growth Debuts enhanced greenhouse gas accounting across Scopes 1-3 and advances renewable energy initiatives Strengthens governance …
Nanobiotix Provides First Quarter 2025 Operational and Financial Update
GlobeNewswire
·
May 21, 2025
Dosing of a first patient in the CONVERGE study, a Phase 2 randomized controlled clinical trial for patients with stage 3 unresectable non-small cell lung cancer Presentation of data at the European Lung Cancer Conference in a Phase 1 study of re- …
Codexis to Participate in Jefferies Global Healthcare Conference
GlobeNewswire
·
May 21, 2025
REDWOOD CITY, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will attend the Jefferies Global Healthcare …
Maravai LifeSciencesReleases 2024 Sustainability Report
GlobeNewswire
·
May 21, 2025
Accelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to responsible growth Debuts enhanced greenhouse gas accounting across Scopes 1-3 and advances renewable energy initiatives Strengthens governance …
Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference
GlobeNewswire
·
May 21, 2025
SOUTH SAN FRANCISCO, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that the Company led oral and poster presentations of clinical and preclinical data this week as part of the American Thoracic Society ( …
Immix Biopharma to Host KOL Event to Discuss NXC-201 Clinical Data Presented at ASCO 2025 in relapsed/refractory AL Amyloidosis
GlobeNewswire
·
May 21, 2025
– Virtual KOL Event Tuesday, June 3, 2025 3:00pm ET – – Attend the event here: https://lifescievents.com/event/immix-asco – LOS ANGELES, CA, May 21, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), clinical- …
AI와 알고리즘 구동 플랫폼 TrialWire, Fierce CRO Award “우수 환자 모집 및 유지” 부문 최종 후보로 선정
GlobeNewswire
·
May 21, 2025
샌프란시스코, May 22, 2025 (GLOBE NEWSWIRE) -- TrialWire가 Fierce Biotech의 Fierce CRO Award 우수 환자 모집 및 유지 부문에서 최종 후보로 선정되었다. TrialWire는 AI와 알고리즘으로 구동되는 환자 모집 및 등록 플랫폼으로, Salesforce Health Cloud를 기반으로 설계되어 최상급의 데이터 및 IP 보안을 보장한다. 이 플랫폼은 등록 환자당 요금을 지불하는 위험 분담형 …
人工智能和算法驱动的平台 TrialWire 荣获 Fierce CRO 奖项“杰出患者招募与留存”类目提名，进入决赛阶段
GlobeNewswire
·
May 21, 2025
旧金山, May 22, 2025 (GLOBE NEWSWIRE) -- TrialWire 今日宣布荣获 Fierce Biotech 主办的 Fierce CRO 奖项杰出患者招募与留存类目提名，闯入决赛。 TrialWire 是基于 Salesforce Health Cloud 构建的人工智能和算法驱动的患者招募和入组特色平台，具备一流的数据和知识产权安全保障。 …
MediPharm Labs Alerts Shareholders to Allegations Made Against Regan McGee in Multiple Litigation Filings
GlobeNewswire
·
May 21, 2025
TORONTO, May 21, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today alerted its shareholders to publicly available information about Regan …
Global AI in Diagnostics Market to Register Stunning Growth at a CAGR of ~22% by 2032 | DelveInsight
GlobeNewswire
·
May 21, 2025
New York, USA, May 21, 2025 (GLOBE NEWSWIRE) -- Global AI in Diagnostics Market to Register Stunning Growth at a CAGR of ~22% by 2032 | DelveInsight The increasing incidence of infectious and chronic illnesses is boosting the need for early and precise …
Aware Recovery Care Appoints Roy Sasenaraine as Chief Executive Officer
GlobeNewswire
·
May 21, 2025
Wallingford, CT, May 21, 2025 (GLOBE NEWSWIRE) -- Aware Recovery Care (“Aware”), a pioneer in in-home addiction treatment, today announced the appointment of Roy Sasenaraine, MBA, as Chief Executive Officer. Sasenaraine previously served as Chief Operating …
Joule Health & Wellbeing Offers Same-Day Stress Support, Providing a Scalable Solution for HR Leaders Addressing Burnout
GlobeNewswire
·
May 21, 2025
Spokane, WA , May 21, 2025 (GLOBE NEWSWIRE) -- In recognition of Mental Health Awareness Month, Joule Health …
Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilars
GlobeNewswire
·
May 21, 2025
MEDIA RELEASE Pyzchiva® first ustekinumab biosimilar in Europe commercially available in pre-filled pen (autoinjector), offering improved self-administration experience for better treatment adherence and quality of life [1-10] Autoinjector includes unique …
Sutter Health and Rivet School Launch Workforce Development Approach to Help Staff Continue Education, Advance Careers
GlobeNewswire
·
May 21, 2025
NORTHERN CALIFORNIA, May 21, 2025 (GLOBE NEWSWIRE) -- Sutter Health and Rivet School are teaming up to provide non-clinical employees with a flexible and affordable online opportunity to earn an accredited associate or bachelor’s degree —and open doors to …
SPRINT® PNS Meets Primary Endpoint of Reduction in Head Pain in First Publication of Multicenter Prospective MONARCH™ Study
GlobeNewswire
·
May 21, 2025
CLEVELAND, May 21, 2025 (GLOBE NEWSWIRE) -- Today, SPR announced the publication of the MONARCH (Multicenter Occipital Neuralgia and Cervicogenic Headache) Study, which evaluates the use of 60-day SPRINT PNS treatment in relieving pain by delivering …